Etoposide is a commonly used chemotherapy agent with a broad range of antitumor activity. Etoposide and teniposide, the epipodophyllotoxins, stabilize the double-stranded DNA cleavage normally catalyzed by topoisomerase II (topo II) and inhibit faithful religation of DNA breaks [1, 2] . These double-strand DNA breaks subsequently trigger the desired antitumor effects of the drugs. Metabolism of etoposide is mediated by CYP3A4 and CPY3A5 (Fig. 1) [3, 4] , both of which are transcriptionally regulated by NR1I2 (i.e. pregnane X receptor). Thus, xenobiotics that modulate NR1I2 activity (e.g. dexamethasone and rifampicin) have been observed to enhance etoposide clearance [5, 6] . In addition to CYP3A4/5 mediated reactions, conversion of etoposide to the O-demethylated metabolites (catechol and quinone) can also be catalyzed by prostaglandin synthases or myeloperoxidase [7] [8] [9] . These metabolites have similar potency at inhibiting topoisomerase II and are more oxidatively reactive than the parent drug [10] . Glutathione [11] and glucuronide conjugation [12] seem to inactivate parent drug and metabolite, and are mediated by GSTT1/GSTP1 and UGT1A1 [13, 14] , respectively. Efflux of conjugated or unconjugated forms of etoposide has been associated with ABCC1, ABCC3, and ABCB1 [15, 16] , representing plausible mechanisms of drug resistance. Epipodophyllotoxins are highly effective anticancer agents, but can cause a delayed toxicity: treatment-related acute myeloid leukemia or myelodysplastic syndrome [17] [18] [19] . Drug-induced formation of MLL fusion genes has been associated with the development of treatment-related acute myeloid leukemia or myelodysplastic syndrome [20] . Although etoposide inhibits both topo II alpha and beta, the antitumor activity of etoposide is shown to be delivered primarily through inhibition of topo II alpha [21] , whereas the carcinogenic effect has been attributed to the beta isoform [22] . Recently, 64 genetic variants that contribute to etoposide-induced cytotoxicity were identified through a whole-genome association study [23] .
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